Oncolytic HSV infection of cancer cells relies on increased expression of multiple receptors in cancer cells such as herpesvirus entry mediator (HVEM), a member of the TNF superfamily, and nectin-1 [18]. This evidence concerns the gene NECTIN1 and cancer.